Intervention Review

Ziprasidone versus other atypical antipsychotics for schizophrenia

  1. Katja Komossa1,*,
  2. Christine Rummel-Kluge1,
  3. Heike Hunger1,
  4. Sandra Schwarz1,
  5. Paranthaman Sethupathi Bhoopathi2,
  6. Werner Kissling1,
  7. Stefan Leucht1

Editorial Group: Cochrane Schizophrenia Group

Published Online: 20 JAN 2010

Assessed as up-to-date: 29 APR 2007

DOI: 10.1002/14651858.CD006627.pub2

Database Title

Additional Information

How to Cite

Komossa K, Rummel-Kluge C, Hunger H, Schwarz S, Bhoopathi PS, Kissling W, Leucht S. Ziprasidone versus other atypical antipsychotics for schizophrenia. Cochrane Database of Systematic Reviews 2009, Issue 4. Art. No.: CD006627. DOI: 10.1002/14651858.CD006627.pub2.

Author Information

  1. 1

    Technische Universität München Klinikum rechts der Isar, Klinik und Poliklinik für Psychiatrie und Psychotherapie, München, Germany

  2. 2

    Coimbatore(Dt) Tamilnadu, India

*Katja Komossa, Klinik und Poliklinik für Psychiatrie und Psychotherapie, Technische Universität München Klinikum rechts der Isar, Moehlstrasse 26, München, 81675, Germany. k.komossa@lrz.tu-muenchen.de.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 20 JAN 2010

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Summary (60K)Standard (432K)Full (950K)

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via Athens http://onlinelibrary.wiley.com/athens or other institutional login options http://onlinelibrary.wiley.com/login-options .
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

View Full Article (HTML) Summary (60K)Standard (432K)Full (950K)